Key Details
Price
$3.65Annual ROE
213.71%Beta
1.40Events Calendar
Next earnings date:
Feb 28, 2025Recent quarterly earnings:
Nov 7, 2024Recent annual earnings:
Feb 28, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Jan 17, 25 Needham
HoldDec 23, 24 Barclays
Equal-WeightDec 10, 24 Mizuho
NeutralNov 8, 24 Needham
HoldNov 8, 24 HC Wainwright & Co.
NeutralOct 28, 24 Needham
HoldSep 13, 24 Barclays
Equal-WeightAug 13, 24 Needham
HoldAug 12, 24 William Blair
Market PerformAug 12, 24 Guggenheim
NeutralMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Revance Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Revance Therapeutics?
- Does Revance Therapeutics pay dividends?
- What sector is Revance Therapeutics in?
- What industry is Revance Therapeutics in?
- What country is Revance Therapeutics based in?
- When did Revance Therapeutics go public?
- Is Revance Therapeutics in the S&P 500?
- Is Revance Therapeutics in the NASDAQ 100?
- Is Revance Therapeutics in the Dow Jones?
- When was Revance Therapeutics's last earnings report?
- When does Revance Therapeutics report earnings?
- Should I buy Revance Therapeutics stock now?
What is the ticker symbol for Revance Therapeutics?
The ticker symbol for Revance Therapeutics is NASDAQ:RVNC
Does Revance Therapeutics pay dividends?
No, Revance Therapeutics does not pay dividends
What sector is Revance Therapeutics in?
Revance Therapeutics is in the Healthcare sector
What industry is Revance Therapeutics in?
Revance Therapeutics is in the Biotechnology industry
What country is Revance Therapeutics based in?
Revance Therapeutics is headquartered in United States
When did Revance Therapeutics go public?
Revance Therapeutics's initial public offering (IPO) was on February 6, 2014
Is Revance Therapeutics in the S&P 500?
No, Revance Therapeutics is not included in the S&P 500 index
Is Revance Therapeutics in the NASDAQ 100?
No, Revance Therapeutics is not included in the NASDAQ 100 index
Is Revance Therapeutics in the Dow Jones?
No, Revance Therapeutics is not included in the Dow Jones index
When was Revance Therapeutics's last earnings report?
Revance Therapeutics's most recent earnings report was on Nov 7, 2024
When does Revance Therapeutics report earnings?
The next expected earnings date for Revance Therapeutics is Feb 28, 2025
Should I buy Revance Therapeutics stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions